Global Nexus for Pandemics and Biological Threats
Preventing the Next Pandemic
Now is the time for Canada to seize the opportunity sparked by COVID-19 and create a nexus that brings together our world-class resources, elevates our capabilities and amplifies impact. McMaster’s researchers are leading the way. Join us.
Impact Areas
Featured Stories
New treatment demonstrated for people with vaccine clots
A new lifesaving treatment for people suffering from vaccine-related blood clots has been demonstrated by researchers at the McMaster Platelet Immunology Laboratory (MPIL).
McMaster-led study investigating COVID-19 immune response in South Asian communities
Approximately $1.5 million is being invested in this study, which will seek to understand vaccine confidence and hesitancy in this population that has been disproportionately affected by COVID-19.
Study on COVID-19 and young adults finds decreases in drinking, but spikes in mental health symptoms, especially in women
In one of the first longitudinal studies on COVID-19’s psychological effects, a McMaster University-led study found notable drops in alcohol use, but significant worsening of mental health, especially in young women and those experiencing a major income loss.
Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms
Infectious disease and hematology experts answer questions about rare vaccine-related blood clots, including risks, symptoms and whether people who have had one AstraZeneca shot should have a second.
Flu-fighter: Researchers develop a new vaccine to broaden and boost protection offered by seasonal flu shots
The vaccine, made of disease-fighting proteins, could boost efficacy, use smaller doses, accelerate production of seasonal flu vaccines.
Biofilms and Bones: McMaster researchers awarded prestigious HFSP grants
Canada’s Global Nexus researcher and biochemist John Whitney and biomedical and materials professor Kathryn Grandfield have received prestigious grants worth more than $2 million from the Human Frontier Science Program (HFSP) for ambitious international projects that span multiple disciplines including infectious disease research.
EXPERT VIDEOS
Understanding COVID-19 variants of concern Learn More
Canada’s Global Nexus researcher Andrew McArthur talks about the risks posed by COVID-19 variants and what Canadians need to do to stay safe.
Overcoming vaccine hesitancy Learn More
Canada’s Global Nexus researcher Matt Miller talks about the safety and effectiveness of COVID-19 vaccines.
This isn’t the first pandemic and it won’t be the last Play Video
Infectious disease researcher Gerry Wright and virologist Karen Mossman explain how the Global Nexus for Pandemics and Biological Threats is a global leader in responding to the current COVID–19 pandemic and in preparing for the next.